.svg?iar=0&hash=CE44290BD6EB1AA03E0D3E0C6F993C3D)
ADCAN Pharma: A Healthcare Success Story in KEZAD
ADCAN Pharma
ADCAN Pharma, UAE’s leading pharmaceutical company was founded in 2013, in Abu Dhabi. It was envisioned in alignment with Abu Dhabi’s strategic vision to become the region’s prime hub for world-class healthcare infrastructure. Within a decade of its establishment, the company has grown to become a major exporter of pharmaceutical products in the GCC, CIS, Africa and other markets around the world.
ADCAN Pharma’s diverse portfolio of drugs span three distinct categories – General, comprising cardiology, diabetes, gastro-intestinal, infectious diseases, and Oncology and Hormones medicines. The company operates out of three factories in ICAD (Industrial City of Abu Dhabi) operated by KEZAD and boasts a product portfolio of 28 SKUs, with 26 more expected by Q2 2025.
ADCAN Pharma is the first and currently the only Oncology and Hormones Manufacturer in UAE. ADCAN pharma is equipped with dedicated Research & Development laboratory where dedicated scientists are involved in discovering new techniques through extensive in-depth research that enable to design, manufacture, and deliver the highest quality products.
With over a decade of operations under its belt, ADCAN Pharma has built a reputation for producing high-quality medicines matching the highest Good Manufacturing Practice (GMP) standards. They recount their successful journey in KEZAD, and how its strategic location and well-planned infrastructure for health have enabled their growth.
REQUIREMENTS
The pharma industry relies on an ecosystem that provides a manufacturing and import-export advantage and is also a base for extensive scientific research and development. ADCAN Pharma wanted to leverage this support system offered by Abu Dhabi’s industrial health zone for future drug development. With this aim, they wanted to establish their facility in a space that matched the highest international standards and specifications, and a system that offered them incentives to expand their product portfolio, innovate and grow in the region, as well as to enter new markets. Local manufacturing is crucial for the growth of UAE’s health industry and ADCAN Pharma aimed to be an important player in this growth.
SOLUTION
ADCAN Pharma’s significant strides in the pharma industry are underscored by their quick adaptation to market dynamics, aided by KEZAD’s evolving health infrastructure and friendly business policies that encourage local manufacturing. The company’s advanced facility works with cutting-edge technologies to produce affordable medicines that are made accessible by KEZAD’s exceptionally engineered port-zone ecosystem. Apart from being equidistant to Abu Dhabi and Dubai, KEZAD facilitates ADCAN Pharma with easy access to GCC via its highway network and proximity to main ports. ADCAN Pharma has been accredited by multiple countries including GCC states, which is proof of their strength as a pharmaceutical company and their emerging supply chain efficiency.
OUTCOME
ADCAN Pharma has been growing expeditiously and their three-phase development includes expanding into the GCC and Africa in the first phase, Europe in the second, and the US in the third. With a production capacity of 500,000 tablets, potentially to double up to 1 billion in general medicines, 200 million in cancer and 150 million in hormonal health, ADCAN Pharma is poised to be the regional leader in serving healthcare markets around the globe. Driven by their mantra to believe in excellence, ADCAN Pharma is championing major investments in research, currently working with more than 20 top scientists and building strategic relationships for healthcare innovation and development. ADCAN Pharma’s vision to ‘go global with local’ aligns with the government’s Make It In The Emirates programme, and anchored by KEZAD, the company is conscientiously partnering in this ambitious national vision to achieve self-sufficiency in a sector as vital as health, and earn global recognition.